Close Menu

NEW YORK ─ The US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) has awarded an additional $4 million to First Light Diagnostics to support continued development of the firm's MultiPath platform along with a rapid test to identify victims of an anthrax attack, the Chelmsford, Massachusetts-based diagnostics company said on Tuesday.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.